A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

September 7, 2020

Primary Completion Date

June 4, 2025

Study Completion Date

June 4, 2025

Conditions
Advanced Solid Tumors
Interventions
DRUG

SHR-A1811

be administered via intravenous (IV) infusion

Trial Locations (35)

333

Chang Gung Memorial Hospital, Linkou, Taoyuan District

2109

Macquarie University Hospital, Macquarie

3004

Nucleus Network, Melbourne

Alfred Hospital, Melbourne

3080

Seoul National University Hospital, Seoul

3199

Peninsula and South Eastern Haematology & Oncology Group, Frankston

5042

Southern Oncology Clinical Research Unit, Bedford Park

5505

Asan Medical Center, Seoul

10461

Montefiore-Einstein Center for Cancer Care, The Bronx

13620

Seoul National University Bundang Hospital, Seongnam-si

29605

Greenville Hospital System, Greenville

40447

China Medical University Hospital, Taichung

70457

National Cheng Kung University Hospital, Tainan City

75230

Mary Crowley Cancer Research, Dallas

100021

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

110022

Shengjing Hospital of China medical university, Shengyang

200032

Fudan University Shanghai cancer center, Shanghai

Fudan Unversity Zhongshan Hospital, Shanghai

Shanghai Jiao Tong University School of Medicine Renji Hospital, Shanghai

210000

Jiangsu Province Hospital, Nanjing

210008

Nanjing Drum Tower Hospital, Nanjing

233000

The first affiliated hospital of bengbu medical college, Bengbu

300181

Tianjin medical university cancer institute&hoospital, Tianjin

310014

The second affiliated hospital Zhejiang university school of medicine, Hangzhou

Zhejiang provincial people's hospital, Hangzhou

350000

Fujian Cancer Hospital, Fujian

410008

Xiangya hospital central south university, Changsha

410031

Hunan cancer hospital, Changsha

430062

Zhongnan hospital of Wuhan university, Wuhan

430079

Hubei cancer hospital, Wuhan

450003

Henan cancer Hospital, Zhengzhou

510120

Nanfang Hospital, Guangzhou

Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou

610042

Sichuan Cancer Hospital, Chengdu

030000

Shanxi Cancer Hospital, Taiyuan

All Listed Sponsors
collaborator

Atridia Pty Ltd.

INDUSTRY

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04446260 - A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors | Biotech Hunter | Biotech Hunter